Fig. 2
From: Identification of endonuclease domain-containing 1 as a novel tumor suppressor in prostate cancer
ENDOD1 expression in prostate cancer cell lines. a ENDOD1 and GAPDH mRNA were determined by quantitative PCR in immortalized epithelial cells (RWPE-1) and PCa cells (22Rv1, LNCaP, PC3 and DU145). Data were represented as relative expression (mean ± S.E.M.) standardized by endogenous expression of GAPDH. *P < 0.05. b-c The cell lysates were immunoblotted with anti-ENDOD1 and anti-GAPDH antibodies, respectively. Experiments were performed at least three times in triplicate